News Focus
News Focus
icon url

DewDiligence

05/15/19 10:58 AM

#225005 RE: DewDiligence #224736

PFE—FDA approves Bavencio/Inlyta combination in first-line RCC:

https://finance.yahoo.com/news/fda-approves-bavencio-avelumab-plus-002500175.html

The FDA recently approved Keytruda/Inlyta in the same indication (#msg-148355182), so it’s unclear whether Bavencio/Inlyta will get much commercial uptake.